Report Overview
Sacral neuromodulation (SNM), also referred to as sacral nerve stimulation, is a medical technology involving implantable devices that deliver mild electrical pulses to the sacral nerves—nerves located near the base of the spine responsible for bladder, bowel, and pelvic floor function.
The sacral neuromodulation system typically comprises an implantable pulse generator (IPG), a lead (electrode), and an external programmer. These systems are predominantly used to treat conditions such as overactive bladder (OAB), urinary retention, fecal incontinence, and other pelvic floor dysfunctions resistant to conservative treatments.
SNM works by modulating neural pathways, correcting the miscommunication between the brain and the bladder or bowel, thereby restoring normal function. The devices can be rechargeable or non-rechargeable, and the latest models support features like full-body MRI compatibility, advanced programmability, and battery life exceeding 15 years.
Regional Analysis
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Competitor Analysis
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Market Segmentation
By Application:
Urinary and Fecal Incontinence
ChronicAnal Fissure
Urge Incontinence
Others
By Type:
Internal Neuromodulation System
External Neuromodulation System
